TITOMIC
Titomic has signed a Heads of Agreement with Neos International Limited to form a joint venture in the United Kingdom which will manufacture and sell Invar 36 Faceplates and multi-metal product solutions for the Aerospace, Defence, Automotive and Nuclear industries. The products will be manufactured using Titomic’s Kinetic Fusion (TKF) Technology and Neos’ specialist engineering and tooling expertise.
The Neos Titomic joint venture will enhance the rapid delivery of Invar and Nickel Shell Tooling and related products to the Aerospace and other vital sectors. The rapid delivery of TKF manufactured tools will assist in the uptake of next generation carbon fibre composite technologies, critical for the production of lightweight fuel-efficient aircraft and equipment to support the UK’s Aircraft and Space Industries.
This joint venture will ensure the high-rate production of mould tools, nickel tools and Defence solutions across the UK supply chain, supporting the UK’s position on next-generation aircraft.
Aircraft manufacturers routinely experience extremely long lead times for tooling required to manufacture carbon fibre parts, caused by limitations of cast and wrought manufacturing. To assist industry in meeting this demand, Titomic has undertaken two years of extensive R&D to validate TKF manufacturing for tooling. This work has culminated in an effective manufacturing process and a commercial relationship with Neos to bring the technology to the UK.
Traditionally, Invar tooling is manufactured by machining billets or casting, which results in up to 90% material wastage or porous tools, respectively. The TKF process addresses these challenges by manufacturing near-net-shape faceplates requiring only 10-20% of material to be machined away to create a finished faceplate in a substantially shorter time. With only 0.5% porosity, these tools exceed all vacuum leak testing standards for aerospace carbon fibre moulding.
With these benefits, clients reduce costs, lead times, and waste thus improving overall productivity.
This joint venture highlights Titomic’s growth strategies, ensuring that the TKF technology adds value and capability to industries around the world.
About NÉOS International Limited:
NÉOS International Limited is a UK headquartered engineering group, supporting many of the world’s leading OEM’s by providing innovative solutions from multiple technology centre’s within the UK, Portugal and India. Please visit: www.neosintl.com
About TITOMIC Limited:
For more information please visit: www.titomic.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005034/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lenovo Finds 65% of IT Leaders Admit Their Defenses Can’t Withstand AI Cybercrime18.9.2025 15:00:00 CEST | Press release
New Lenovo Research Shows How AI-Powered Defenses Help Enterprises Turn Cyber Risk into Cyber Resilience Lenovo research reveals a widening security gap as AI-driven cybercrime surges: 65% of IT leaders surveyed admit their defenses are outdated and unable to withstand AI-enabled attacks, and just 31% feel confident defending against them. The new insights are drawn from Lenovo’s third Work Reborn report, Reinforcing the Modern Workplace. While AI is driving business improvements and efficiency gains, it is also fueling a new wave of cybercrime that most businesses are ill-equipped to defend against. This underscores the critical need for enterprises to adopt AI-driven strategies that can counter threats that learn, adapt, and evolve in real time. Lenovo is positioned to deliver this shift with end-to-end solutions that embed AI security into the digital workplace. With operations in 180 markets and a leader in enterprise technology, Lenovo brings unmatched scale to solving AI workplac
Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 15:00:00 CEST | Press release
With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. Taking place on October 15, 2025, at the iconic Shangri-La at The Shard in London, Elevate'25 moves beyond the headlines to provide a practical roadmap for success, featuring insights from brand executives and ind
Armis Receives Morgan Stanley 2025 Innovation Award18.9.2025 15:00:00 CEST | Press release
Armis Centrix™ Platform, powered by Armis’ AI driven cyber security intelligence engine, manages over 6.5 billion assets daily making it the largest of its kind in the world Armis, the cyber exposure management & security company, today announced that it has received the prestigious Innovation Award from Morgan Stanley at the Firm’s 23rd Tech Week event in Silicon Valley. For over 20 years, Morgan Stanley has celebrated companies with innovative capabilities that have materially impacted its business. Armis is being recognized for its partnership with Morgan Stanley, which chose Armis to help protect and secure its critical internet-of-things (IoT) assets across its organization. “Continuous and cutting-edge innovation that enables global cybersecurity teams to combat malicious actors is essential in today’s environment. The attack surface is growing exponentially, and Armis’ mission is to protect organizations’ entire attack surface by managing cyber risk exposure in real time,” said
Scoring Big With Fans: Balchem Spotlights the Power of Vitamin K2 at FC Bayern Women’s Season Opener18.9.2025 14:33:00 CEST | Press release
Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health – and official partner of FC Bayern (FCB) Women’s football team - has launched its first ever direct-to-consumer initiative, showcasing the power of vitamin K2 to FCB fans. The company promoted its K2VITAL™ brand with an exhibition stand at the Allianz Arena in Munich, during the opening game of the Bundesliga (German football league) on 6 September. This initiative is part of Balchem’s latest marketing strategy, which aims to raise consumer awareness of the health benefits vitamin K2 has to offer, bridging the gap between B2B and B2C markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918950889/en/ Balchem Spotlights The Power of Vitamin K2 at FC Bayern Women’s Season Opener Co-Branded K2 Health Vitamins Hit the Pitch The opening event of the season provided a unique platform for Balchem to promote K2VITAL™, a patented, typ
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy18.9.2025 14:30:00 CEST | Press release
- CASGEVY is the first, and only, gene editing therapy approved for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD) in Europe -- Italy has the largest population of people living with TDT in Europe- Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with the Italian Medicines Agency (AIFA) for eligible transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel). “Today is a turning point for eligible people in Italy living with transfusion-dependent beta thalassemia and sickle cell disease, two life-shortening diseases with limited treatment options,” said Ludovic Fenaux, Senior Vice President, Vertex International. “Italy has the largest TDT population in Europe, which underscores the importance of this agreement. We appreciate the collaboration with AIFA to recognize the value a one-time transformati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom